Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (211-220 of 494) with videos related to

Pageof 50
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2008
Clinical significance of p53 alterations in surgically treated prostate cancersThorsten Schlomm, Liv Iwers, Patrick Kirstein, et al.
Breast Cancer (Tokyo, Japan)|May 28, 2014
Cyclin D1 gene amplification is highly homogeneous in breast cancerEike Burandt, Martin Grünert, Annette Lebeau, et al.
Cancer Research|February 4, 2015
Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancerVerena Thewes, Ronald Simon, Petra Schroeter, et al.
The American Journal of Pathology|September 18, 2010
Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosisTorsten Stein, Emilio Cosimo, Xinzi Yu, et al.
Lung Cancer (Auckland, N.Z.)|January 14, 2026
Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung CancerNina Schraps, Martin Reck, Birgit Hantzsch-Kuhn, et al.
International Journal of Cancer|October 12, 2020
Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancerKatharina Möller, Martina Kluth, Malik Ahmed, et al.
International Journal of Oncology|August 4, 2004
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumorsEva Klopocki, Glen Kristiansen, Peter J Wild, et al.
BMC Cancer|July 24, 2015
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletionChristoph Burdelski, Devi Menan, Maria Christina Tsourlakis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 23, 2006
High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi ArabiaKhawla Al Kuraya, Abdul Khalid Siraj, Prashant Bavi, et al.
International Journal of Cancer|April 29, 2025
Patient-derived tumor organoids highlight the potential of precision medicine in managing pancreatic ductal adenocarcinomaChristine Nitschke, Charline Phan, Yara Souto, et al.
Pageof 50

Showing results (211-220 of 494) with videos related to

Sort By:
Pageof 50
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2008
Clinical significance of p53 alterations in surgically treated prostate cancersThorsten Schlomm, Liv Iwers, Patrick Kirstein, et al.
Breast Cancer (Tokyo, Japan)|May 28, 2014
Cyclin D1 gene amplification is highly homogeneous in breast cancerEike Burandt, Martin Grünert, Annette Lebeau, et al.
Cancer Research|February 4, 2015
Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancerVerena Thewes, Ronald Simon, Petra Schroeter, et al.
The American Journal of Pathology|September 18, 2010
Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosisTorsten Stein, Emilio Cosimo, Xinzi Yu, et al.
Lung Cancer (Auckland, N.Z.)|January 14, 2026
Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung CancerNina Schraps, Martin Reck, Birgit Hantzsch-Kuhn, et al.
International Journal of Cancer|October 12, 2020
Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancerKatharina Möller, Martina Kluth, Malik Ahmed, et al.
International Journal of Oncology|August 4, 2004
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumorsEva Klopocki, Glen Kristiansen, Peter J Wild, et al.
BMC Cancer|July 24, 2015
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletionChristoph Burdelski, Devi Menan, Maria Christina Tsourlakis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 23, 2006
High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi ArabiaKhawla Al Kuraya, Abdul Khalid Siraj, Prashant Bavi, et al.
International Journal of Cancer|April 29, 2025
Patient-derived tumor organoids highlight the potential of precision medicine in managing pancreatic ductal adenocarcinomaChristine Nitschke, Charline Phan, Yara Souto, et al.
Pageof 50